Pictet Asset Management Holding SA Increases Stock Position in The Cooper Companies, Inc. (NASDAQ:COO)

Pictet Asset Management Holding SA raised its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 7.1% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 145,085 shares of the medical device company’s stock after purchasing an additional 9,650 shares during the period. Pictet Asset Management Holding SA’s holdings in Cooper Companies were worth $13,338,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors have also recently made changes to their positions in COO. Fulton Bank N.A. grew its stake in shares of Cooper Companies by 3.0% in the 4th quarter. Fulton Bank N.A. now owns 3,718 shares of the medical device company’s stock worth $342,000 after buying an additional 109 shares in the last quarter. Torray Investment Partners LLC lifted its holdings in shares of Cooper Companies by 0.8% in the 4th quarter. Torray Investment Partners LLC now owns 16,190 shares of the medical device company’s stock valued at $1,488,000 after acquiring an additional 132 shares during the last quarter. Mather Group LLC. grew its position in Cooper Companies by 7.4% in the fourth quarter. Mather Group LLC. now owns 1,926 shares of the medical device company’s stock worth $177,000 after acquiring an additional 133 shares in the last quarter. MassMutual Private Wealth & Trust FSB increased its stake in Cooper Companies by 15.6% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,008 shares of the medical device company’s stock worth $93,000 after acquiring an additional 136 shares during the last quarter. Finally, Greenleaf Trust raised its position in Cooper Companies by 5.0% during the fourth quarter. Greenleaf Trust now owns 2,915 shares of the medical device company’s stock valued at $268,000 after purchasing an additional 139 shares during the period. 24.39% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on the company. Robert W. Baird cut their target price on Cooper Companies from $117.00 to $107.00 and set an “outperform” rating on the stock in a research report on Friday, March 7th. Piper Sandler reiterated an “overweight” rating and set a $115.00 price objective (down previously from $120.00) on shares of Cooper Companies in a research report on Friday, March 7th. Needham & Company LLC reaffirmed a “hold” rating on shares of Cooper Companies in a research note on Friday, March 7th. BNP Paribas upgraded shares of Cooper Companies to a “hold” rating in a report on Thursday, March 13th. Finally, Wells Fargo & Company raised their price objective on shares of Cooper Companies from $115.00 to $118.00 and gave the stock an “overweight” rating in a research note on Friday, December 6th. Four investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $110.25.

Cooper Companies Stock Down 3.7 %

Shares of NASDAQ COO opened at $81.27 on Wednesday. The stock has a 50 day moving average price of $88.87 and a 200 day moving average price of $96.83. The firm has a market capitalization of $16.25 billion, a price-to-earnings ratio of 41.68, a PEG ratio of 2.25 and a beta of 1.02. The Cooper Companies, Inc. has a 52-week low of $77.05 and a 52-week high of $112.38. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings results on Thursday, March 6th. The medical device company reported $0.92 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.92. The business had revenue of $964.70 million for the quarter, compared to the consensus estimate of $981.25 million. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. Sell-side analysts expect that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.